−0.020AUD
−360.81 KAUD
57.73 MAUD
233.27 M
About AROA BIOSURGERY LIMITED
Sector
Industry
CEO
Brian Roderick Ward
Website
Headquarters
Mangere
Founded
2008
ISIN
NZARXE0001S1
FIGI
BBG00VX929P6
Aroa Biosurgery Ltd. engages in the development, manufacturing, and marketing of soft tissue repair products. It focuses on healing for complex wounds, and soft tissue reconstruction procedures including abdominal wall reconstruction, breast reconstruction, and reconstructive surgery for trauma, limb salvage, and tumor resections. The company was founded by Brian Roderick Ward in 2008 and is headquartered in Mangere, New Zealand.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ARX is 0.535 AUD — it has decreased by 2.73% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange AROA BIOSURGERY LIMITED stocks are traded under the ticker ARX.
AROA BIOSURGERY LIMITED is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for AROA BIOSURGERY LIMITED has a max estimate of 1.205 AUD and a min estimate of 0.890 AUD.
ARX earnings for the last quarter are −0.01 AUD whereas the estimation was −0.01 AUD which accounts for −14.29% surprise. Estimated earnings for the next quarter are −0.01 AUD. See more details about AROA BIOSURGERY LIMITED earnings.
AROA BIOSURGERY LIMITED revenue for the last quarter amounts to 31.07 M AUD despite the estimated figure of 30.69 M AUD. In the next quarter revenue is expected to reach 30.75 M AUD.
Yes, you can track AROA BIOSURGERY LIMITED financials in yearly and quarterly reports right on TradingView.
Like other stocks, ARX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AROA BIOSURGERY LIMITED stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AROA BIOSURGERY LIMITED EBITDA is −5.02 M AUD, and current EBITDA margin is −1.59%. See more stats in AROA BIOSURGERY LIMITED financial statements.